The filing is a routine Form 144 for a small number of shares acquired through vesting. No material insider selling signal; monitor for any larger filings or changes in insider trading patterns.
LH drugs
LH drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $353.92entry
- T+1 · 13d ago +3.92%α +2.27% · $367.79
- T+5 · 7d ago +4.79%α +5.38% · $370.88
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Labcorp officer Bryan T. Vaughn filed a Form 144 notice of intent to sell 306 shares of common stock, with an approximate market value of $108,232 based on the filing. The shares were acquired via restricted stock vesting on 11/01/2026 as compensation. The sale is small relative to the company's $29.9B market cap and the officer's likely total holdings, making it a routine insider transaction.
Key Facts
- Insider: Bryan T. Vaughn (Officer)
- Shares to be sold: 306 shares of common stock
- Approximate value: $108,232.20
- Shares acquired via restricted stock vesting on 11/01/2026 (compensation)
- Proposed sale date: 11/03/2026
- Broker: Fidelity Brokerage Services LLC
- Market cap of Labcorp: $29.9B
Financial Impact
Sale of 306 shares worth ~$108K, representing a negligible fraction of the company's $29.9B market cap.
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur.
- Insider selling could increase if additional filings appear.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007675 |
| Document: 0001959173-26-007675-index.html | 0001959173-26-007675 |
| Document: 0001959173-26-007675.txt | 0001959173-26-007675 |
Track record
29 reports on LH
5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +17.60% at T+60 after the Apr 30, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $372.32 Now $372.46 +0.04% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $372.23 Now $372.46 +0.06% settles Nov 18
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $363.30 to $372.32 Now $372.46 +2.52% ▲ +2.48% −0.81% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 4, 202612d ago 8-K Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Viewing Entry $353.92 to $370.88 Now $372.46 +5.24% ▲ +4.79% +5.38% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $361.39 to $366.57 Now $372.46 +3.06% ▲ +1.43% +4.14% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $360.25 to $367.79 Now $372.46 +3.39% ▲ +2.09% +2.81% vs SPY
- Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $329.90 to $361.39 Now $372.46 +12.90% ▲ +9.55% +10.81% vs SPY
- Oct 21, 202626d ago 8-K Neutral 2/10 Entry $323.75 to $331.17 Now $372.46 +15.05% ▲ +2.29% +2.74% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers